The estimated Net Worth of Management Ltd Abg Ii So Lt... is at least $1.5 millió dollars as of 12 September 2018. Management Lt owns over 297,568 units of Sorrento Therapeutics Inc stock worth over $10,130 and over the last 6 years Management sold SRNE stock worth over $1,493,791.
Management has made over 1 trades of the Sorrento Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Management sold 297,568 units of SRNE stock worth $1,493,791 on 12 September 2018.
The largest trade Management's ever made was selling 297,568 units of Sorrento Therapeutics Inc stock on 12 September 2018 worth over $1,493,791. On average, Management trades about 297,568 units every 0 days since 2018. As of 12 September 2018 Management still owns at least 1,013,020 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Management Lt stock trades at the bottom of the page.
Management's mailing address filed with the SEC is 3004 30th St #3002, Des Moines, IA 50310, USA.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee és Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: